When tumor cells interact with PD-1 on T cells via PDL-1, the PI3K/AKT pathway is inhibited, leading to cell cycle arrest and T cell activity inhibition (Buchbinder and Desai, 2016) (Figure 1). This evidence concerns the gene PDCD1 and neoplasm.